ArticleFrontiers in pharmacology2021

Safety, Tolerability, and Pharmacokinetics of a Novel Mitochondrial Modulator, TRC150094, in Overweight and Obese Subjects: A Randomized Phase-I Clinical Trial.

Deepa Joshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.